Literature DB >> 19747204

The clinical presentation of mitochondrial diseases in children with progressive intellectual and neurological deterioration: a national, prospective, population-based study.

Christopher M Verity1, Anne Marie Winstone, Lesley Stellitano, Deepa Krishnakumar, Robert Will, Robert McFarland.   

Abstract

AIM: Our aim was to study the clinical presentation, mode of diagnosis, and epidemiology of mitochondrial disorders in children from the UK who have progressive intellectual and neurological deterioration (PIND).
METHOD: Since April 1997, we have identified patients aged 16 years or younger with suspected PIND through the monthly notification card sent to all UK consultant paediatricians by the British Paediatric Surveillance Unit. Clinical details obtained from reporting paediatricians are classified by an Expert Group.
RESULTS: By July 2008, 2493 cases of PIND had been reported, among which there were 112 children (69 males, 43 females) with mitochondrial diseases presenting between birth and 14 years 7 months (median 12mo), divided into 13 subgroups. In some instances, clinical features were characteristic of mitochondrial disease, but many children presented non-specifically with combinations of developmental delay, hypotonia, failure to thrive, and seizures; 16 children had multisystem disease at presentation. Mortality was high: 40 children had died. Blood and/or cerebrospinal fluid lactate measurements were abnormal in 87 children, and 47 of 78 brain magnetic resonance images showed increased basal ganglia signal. Definite diagnoses were usually made by muscle enzyme or genetic studies.
INTERPRETATION: This is a unique population-based study of the mitochondrial disorders that cause childhood neurodegenerative disease. It provides detailed information about the clinical presentation and investigation of these complex cases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19747204     DOI: 10.1111/j.1469-8749.2009.03463.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  9 in total

1.  8-year retrospective analysis of intravenous arginine therapy for acute metabolic strokes in pediatric mitochondrial disease.

Authors:  Rebecca D Ganetzky; Marni J Falk
Journal:  Mol Genet Metab       Date:  2018-02-02       Impact factor: 4.797

2.  Neuropsychological and Psychiatric Features of Children and Adolescents Affected With Mitochondrial Diseases: A Systematic Review.

Authors:  Elise Riquin; Philippe Duverger; Cindy Cariou; Magalie Barth; Clément Prouteau; Patrick Van Bogaert; Dominique Bonneau; Arnaud Roy
Journal:  Front Psychiatry       Date:  2020-07-28       Impact factor: 4.157

3.  Mitochondrial Disease in Children: The Nephrologist's Perspective.

Authors:  Paula Pérez-Albert; Carmen de Lucas Collantes; Miguel Ángel Fernández-García; Teresa de Rojas; Cristina Aparicio López; Luis Gutiérrez-Solana
Journal:  JIMD Rep       Date:  2017-12-17

4.  Understanding structure, function, and mutations in the mitochondrial ATP synthase.

Authors:  Ting Xu; Vijayakanth Pagadala; David M Mueller
Journal:  Microb Cell       Date:  2015-04-01

5.  Autism and intellectual disability associated with mitochondrial disease and hyperlactacidemia.

Authors:  José Guevara-Campos; Lucía González-Guevara; Omar Cauli
Journal:  Int J Mol Sci       Date:  2015-02-11       Impact factor: 5.923

Review 6.  Early Disruption of the Microbiome Leading to Decreased Antioxidant Capacity and Epigenetic Changes: Implications for the Rise in Autism.

Authors:  Rebecca S Eshraghi; Richard C Deth; Rahul Mittal; Mayank Aranke; Sae-In S Kay; Baharak Moshiree; Adrien A Eshraghi
Journal:  Front Cell Neurosci       Date:  2018-08-15       Impact factor: 5.505

7.  Frequency of inborn errors of metabolism screening for children with unexplained acute encephalopathy at an emergency department.

Authors:  Mamdouh Abdel Maksoud; Solaf Mohamed ELsayed; Rania H Shatla; Abdulbasit Abdulhalim Imam; Riad M Elsayed; Amira Aa Mosabah; Ashraf M Sherif
Journal:  Neuropsychiatr Dis Treat       Date:  2018-06-29       Impact factor: 2.570

8.  Effectiveness of whole exome sequencing in unsolved patients with a clinical suspicion of a mitochondrial disorder in Estonia.

Authors:  Sanna Puusepp; Karit Reinson; Sander Pajusalu; Ülle Murumets; Eve Õiglane-Shlik; Reet Rein; Inga Talvik; Richard J Rodenburg; Katrin Õunap
Journal:  Mol Genet Metab Rep       Date:  2018-03-15

9.  Surveillance for variant CJD: should more children with neurodegenerative diseases have autopsies?

Authors:  Christopher Verity; Anne Marie Winstone; Robert Will; Alison Powell; Peter Baxter; Carlos de Sousa; Paul Gissen; Manju Kurian; John Livingston; Robert McFarland; Suvankar Pal; Michael Pike; Richard Robinson; Evangeline Wassmer; Sameer Zuberi
Journal:  Arch Dis Child       Date:  2018-10-18       Impact factor: 3.791

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.